Volume 22, Issue 2 supplement

October 2004

Filter by

Volume:

Sort by

Date published:

New to old Old to new

11 articles in this issue

Foreword
Christopher-Paul Milne
EditorialNotes 23 September 2012 Pages: v - vii
The economics of follow-on drug research and development
Joseph A. DiMasi
Cherie Paquette
Original Research Article 23 September 2012 Pages: 1 - 14
Are the economics of pharmaceutical research and development changing?
Henry Grabowski
Review Article 23 September 2012 Pages: 15 - 24
The effects of pharmaceutical consumption and obesity on the quality of life in the Organization of Economic Cooperation and Development (OECD) countries
H. E. Frech III
Richard D. Miller Jr
Original Research Article 23 September 2012 Pages: 25 - 36
Changes in the costs of treating mental health disorders
Ernst R. Berndt
Review Article 23 September 2012 Pages: 37 - 50
Impediments to the diffusion of innovative medicines in Europe
Oliver Schöffski
Review Article 23 September 2012 Pages: 51 - 64
The impact of healthcare reform in The Netherlands
Frans Rutten
Review Article 23 September 2012 Pages: 65 - 71
Global principles for better healthcare
Edward Bramley-Harker
Review Article 23 September 2012 Pages: 73 - 79
The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovation
Jerry Avorn
Review Article 23 September 2012 Pages: 81 - 86
The policy implications of gender mainstreaming for healthcare research in the EU
Ineke Klinge
Peggy Maguire
Review Article 23 September 2012 Pages: 87 - 93
Concluding remarks
Kenneth I. Kaitin
Concluding Remarks 23 September 2012 Pages: 95 - 96

Search